Refractory enteric amebiasis in pediatric patients with acute graft- versus-host disease after allogeneic bone marrow transplantation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 31, Issue 1, 2000, Pages 86-90

  Perret, Cecilia ^a   Harris, Paul R ^a   Rivera, Maribel ^a   Vial, Pablo ^a   Duarte, Ignacio ^a   Barriga, Francisco ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; AMEBIASIS; ARTICLE; CASE REPORT; DIARRHEA; ENTAMOEBA HISTOLYTICA; FECES ANALYSIS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; TROPHOZOITE;

ACUTE DISEASE; ADOLESCENT; ANIMALS; BONE MARROW TRANSPLANTATION; CHILD, PRESCHOOL; DYSENTERY, AMEBIC; ENTAMOEBA HISTOLYTICA; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; PREVALENCE; SOCIOECONOMIC FACTORS; TRANSPLANTATION, HOMOLOGOUS;

ENTAMOEBA HISTOLYTICA;

EID: 0033922328     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200007000-00020     Document Type: Article

References (28)

1. Ferrara J, Deeg H. Graft versus host disease. N Engl J Med 1991; 324:667-74.
2. Walash JA. Problems in recognition and diagnosis of amebiasis: estimation of the global magnitude of morbidity and mortality. Rev Infect Dis 1986;8:228-38.
3. Werne Apt. Amebiasis. In: Atias A, Neghme A, ed. Parasitologia clinica. Santiago, Chile: Mediterraneo, 1991:130-41.
4. Biolley MA, Gamboa C, Astete S, Ulloa R. Intestinal infection by parasites and/or hosts in school children of the IX region, Chile. Bol Chil Parasitol 1990;45:86-91.
5. Weitz JC, Astorga B. Serologia para amebiasis. Utilidad clinica e interpretacion. Rev Chilena Infect 1991;8:149-51.
6. Reed S. Amebiasis: An update. Clin Infect Dis 1992;14:385-93.
7. Thorsen S, Ronne-Rasmussen J, Petersen E, Isager H, Seefeldt T, Mathiesen L. Extra-intestinal amebiasis: Clinical presentation in a nonendemic setting. Scand J Infect Dis 1993;25:747-50.
8. Ravdin J. Entamoeba histolytica: From adherence to enteropathy. J Infect Dis 1988;159:420-9.
9. Wanke C, Butler T, Islam M. Epidemiologic and clinical features of invasive amebiasis in Bangladesh: A case-control comparison with other diarrheal diseases and postmortem findings. Am J Trop Med Hyg 1988;38:335-41.
10. Tucker PC, Webster PD, Zachary M, Kilpatrick ZM. Amebic colitis mistaken for inflammatory bowel disease. Arch Intern Med 1975;135:681-5.
11. Reed S, Wessel D, Davis C. Entamoeba histolytica infection and AIDS. Am J Med 1991;90:269-71.
12. Smith P, Lane H, Gill V, et al. Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS): etiology and response to therapy. Ann Intern Med 1988;108:328-33.
13. Adams E, MacLeod I. Invasive amebiasis: II. Amebic liver abscess and its complications. Medicine (Baltimore) 1977;56:325-34.
14. Ferrara J, Krenger W. Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines. Transfus Med Rev 1998;12:1-17.
15. Ghayur T, Seemeyer T, Kongshavn PA. Gartner JG, Lapp WS. Graft versus host reaction in the beige mouse: An investigation of the role of host and donor natural killer cells in the pathogenesis of graft versus host disease. Transplantation 1987;44:261-7.
16. Snover D. The pathology of acute graft-versus-host disease. In: Burakoff S, Deeg H, eds. Graft versus host disease: Immunology, pathophysiology and treatment. New York: Marcel Dekker, Inc, 1990:337-53.
17. Storb R, Deeg H, Fisher L, et al. Cyclosporine versus methotrexate for graft versus host disease in patients given marrow graft for leukemia. Long term follow up of the three controlled trials. Blood 1988;71:293-8.
18. Bavaro P, Di-Girolamo G, Di-Bartolomeo P, et al. Amebiasis after bone marrow transplantation. Bone Marrow Transplant 1994;13: 213-4.
19. Yolken R, Bishop C. Infectious gastroenteritis in bone marrow transplant recipients. N Engl J Med 1988;306:1009-12.
20. Schain D, Salata R, Ravdin J. Human T-lymphocyte proliferation, lympokine production, and amebicidal activity elicited by the galactose-inhibitable adherence protein of Entamoeba histolytica. Infect Immun 1992;60:2143-6.
21. Denis M, Chadee K. Murine T-cell clones against Entamoeba histolytica: In vivo and in vitro characterization. Immunology 1989; 66:76-82.
22. Schain D, Salata R, Ravdin J. Development of amebicidal cell-mediated immunity in gerbils (Meriones unguiculatus) immunized with the galactose-inhibitable adherence lectin of Entamoeba histolytica. J Parasitol 1995;81:563-8.
23. Petri W, Ravdin J. Protection of Gerbils from amebic liver abscess by immunization with the galactose-specific adherence lectin of Entamoeba histolytica. Infect Immun 1991;59:97-101.
24. Villareal B, Melendro E, Ramos F, Ximenez C. Local and systemic antibody response in Balb/c mice immunized with Entamoeba histolytica trophozoites. Arch Med Res 1992;23:69-72.
25. Grant H, Kibbler Ch. Host defence defects and possible approaches to their correction in the bone marrow transplant recipient. Curr Opin Infect Dis 1995;8:229-33.
26. Burchard G, Prange G, Mirelman D. Interaction of various Entamoeba histolytica strains with human intestinal cell lines. Arch Med Res 1992;23:193-5.
27. Stanley S, Virgin H. SCID mice as a model for parasitic infections. Parasitol Today 1993;9:406-11.
28. Storb R, Deeg H, Whitehead J. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986;314:729-35.